108 related articles for article (PubMed ID: 3084411)
41. Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates.
Hiwasa T; Fujiki H; Sugimura T; Sakiyama S
Cancer Res; 1983 Dec; 43(12 Pt 1):5951-5. PubMed ID: 6416671
[TBL] [Abstract][Full Text] [Related]
42. Existence of an optimal dose of dihydroteleocidin B for skin tumor promotion.
Suganuma M; Fujiki H; Sugimura T
Gan; 1982 Aug; 73(4):531-3. PubMed ID: 7152193
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses.
Li X; Eckard J; Shah R; Malluck C; Frenkel K
Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690
[TBL] [Abstract][Full Text] [Related]
44. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Yasukawa K; Iida T; Fujimoto Y
J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
[TBL] [Abstract][Full Text] [Related]
45. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H
Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501
[TBL] [Abstract][Full Text] [Related]
46. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
[TBL] [Abstract][Full Text] [Related]
47. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
Huang MT; Ho CT; Wang ZY; Ferraro T; Lou YR; Stauber K; Ma W; Georgiadis C; Laskin JD; Conney AH
Cancer Res; 1994 Feb; 54(3):701-8. PubMed ID: 8306331
[TBL] [Abstract][Full Text] [Related]
49. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
[TBL] [Abstract][Full Text] [Related]
50. Cell-mediated immune response in mice during the two-step carcinogenesis experiment by 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoylphorbol-13-acetate.
Takeuchi M; Fujiki H; Nitta K
Jpn J Exp Med; 1986 Jun; 56(3):131-4. PubMed ID: 3093738
[TBL] [Abstract][Full Text] [Related]
51. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
[TBL] [Abstract][Full Text] [Related]
52. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters.
Fujiki H; Suganuma M; Yoshizawa S; Kanazawa H; Sugimura T; Manam S; Kahn SM; Jiang W; Hoshina S; Weinstein IB
Mol Carcinog; 1989; 2(4):184-7. PubMed ID: 2508660
[TBL] [Abstract][Full Text] [Related]
53. New classes of environmental tumor promoters: indole alkaloids and polyacetates.
Fujiki H; Sugimura T; Moore RE
Environ Health Perspect; 1983 Apr; 50():85-90. PubMed ID: 6409606
[TBL] [Abstract][Full Text] [Related]
54. New antitumor promoters: (-)-epigallocatechin gallate and sarcophytols A and B.
Fujiki H; Suganuma M; Suguri H; Takagi K; Yoshizawa S; Ootsuyama A; Tanooka H; Okuda T; Kobayashi M; Sugimura T
Basic Life Sci; 1990; 52():205-12. PubMed ID: 1970233
[TBL] [Abstract][Full Text] [Related]
55. Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.
Jeffrey AM; Liskamp RM
Proc Natl Acad Sci U S A; 1986 Jan; 83(2):241-5. PubMed ID: 3079908
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of intercellular communication in Chinese hamster V79 cells by teleocidin.
Jone CM; Trosko JE; Chang C; Fujiki H; Sugimura T
Gan; 1982 Dec; 73(6):874-8. PubMed ID: 6819176
[TBL] [Abstract][Full Text] [Related]
57. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
[TBL] [Abstract][Full Text] [Related]
58. Teleocidin, lyngbyatoxin A and their hydrogenated derivatives, possible tumor promoters, induce terminal differentiation in HL-60 cells.
Nakayasu M; Fujiki H; Mori M; Sugimura T; Moore RE
Cancer Lett; 1981 May; 12(4):271-7. PubMed ID: 6796252
[TBL] [Abstract][Full Text] [Related]
59. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
[TBL] [Abstract][Full Text] [Related]
60. Teleocidin-induced modulation of growth and cell interaction in microenvironment-dependent mouse leukemias.
Kaneshima H; Hiai H; Fujiki H; Iijima S; Sugimura T; Nishizuka Y
Leuk Res; 1983; 7(2):287-93. PubMed ID: 6406773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
